Mylan Pushed for Law to Make EpiPens Mandatory in U.S. Schools—Then Fled Overseas to Avoid Taxes

‘EpiPens are mandatory for public schools in at least 11 states after Congress passed a law recommending their use—but the drug’s manufacturer pays no U.S. taxes at all after relocating overseas.
Mylan spent $4 million lobbying Congress to pass the 2013 School Access to Emergency Epinephrine Act, which offers incentives to schools to stock the potentially lifesaving auto-injectors.
About a year and a half later, Mylan completed a corporate inversion to change its legal residence to the Netherlands, a tax haven, while keeping its headquarters and most of its employees in the Pittsburgh area.’
Read more: Mylan Pushed for Law to Make EpiPens Mandatory in U.S. Schools—Then Fled Overseas to Avoid Taxes